SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Roger's 1997 Short Picks
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Timoteo who wrote (6318)10/30/1997 2:06:00 PM
From: Franco Battista  Read Replies (1) of 9285
 
Timoteo, I would suggest you not short Vivus. I was short this stock at the beginning of the year and made some good money but have noticed since about July that this is a serious company with a good product and is well ahead of the competition. Viagra and Vasomax (from Zonagen) are scheduled for release possibly next year but they have tested poorly so far. In fact, the Pfizer hype machine will actually help VVus as it will make these products more visible. I suggest you inform yourself on the competing products and their side effects before taking any action.
Vvus stock has always behaved this way: prior to earnings it rises on expected blowout numbers and after earnings it crumbles as the momentum players exit en masse. These swings is where the money lies IMHO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News